Investigating how aging affects the heart benefits of menopause hormone therapy
Does Senescence Impair the Cardiovascular Benefits of Menopause Hormone Therapy?
This study is looking at how aging might affect the heart health benefits that postmenopausal women usually get from hormone therapy, using mice to help understand why this therapy doesn't always work as expected for older women.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-11063998 on NIH RePORTER |
What this research studies
This research explores how aging and cellular senescence may hinder the cardiovascular benefits typically associated with menopause hormone therapy (MHT) in postmenopausal women. By using mouse models that simulate postmenopausal conditions, the study aims to understand the mechanisms behind the failure of MHT to reduce atherosclerotic cardiovascular disease (ASCVD) risk despite improvements in metabolic health. The researchers will examine the relationship between inflammation and atherosclerosis in the context of aging, providing insights that could lead to better therapeutic strategies for older women. The findings may help clarify why MHT does not offer the expected cardiovascular protection in aged populations.
Who could benefit from this research
Good fit: Ideal candidates for this research are postmenopausal women, particularly those experiencing cardiovascular issues or at risk for atherosclerotic cardiovascular disease.
Not a fit: Patients who are premenopausal or do not have cardiovascular risk factors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments that effectively reduce cardiovascular disease risk in postmenopausal women.
How similar studies have performed: While the specific approach of this research is novel, previous studies have indicated that inflammation plays a significant role in cardiovascular health, suggesting potential for impactful findings.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Zhu, Lin — Vanderbilt University Medical Center
- Study coordinator: Zhu, Lin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.